Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-12-13Clinical Trial Update: Cetuximab Plus Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Cancer of the Pancreas [Phase 2]
A Phase 2 trial evaluating cetuximab plus gemcitabine for pancreatic cancer (locally advanced, metastatic, or recurrent) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-09-17Clinical Trial Update: Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri-ampullary Tumors; Monocentric Trial on Standard Open Versus Minimally Invasive Surgery
A single-center trial comparing open versus minimally invasive pancreaticoduodenectomy for pancreatic and periampullary tumors has been with…
-
CLINICAL_TRIALS withdrawal · 2013-06-26Clinical Trial Update: OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas [Phase 1, Phase 2]
A Phase 1/2 trial of OSI-906 in combination with gemcitabine and erlotinib for metastatic pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2013-06-24Clinical Trial Update: Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 1, Phase 2]
The trial investigating conatumumab with gemcitabine, capecitabine, and radiation therapy for locally advanced pancreatic cancer has been wi…
-
CLINICAL_TRIALS withdrawal · 2013-05-16Clinical Trial Update: Detection of Cancer-Specific Active Proteases in Blood Via Fluorescence
A clinical trial investigating detection of cancer-specific active proteases in blood using fluorescence for pancreatic cancer has been with…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2013-02-01Clinical Trial Update: Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery [NA]
A clinical trial evaluating gemcitabine, capecitabine, and bevacizumab for pancreatic cancer that can be removed by surgery has been withdra…
-
CLINICAL_TRIALS withdrawal · 2012-09-19Clinical Trial Update: Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer [Phase 1]
A Phase 1 trial evaluating electroporation therapy with bleomycin for pancreatic cancer was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-09-14Clinical Trial Update: Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer [Phase 1]
A Phase 1 trial evaluating radiolabeled monoclonal antibody therapy for gastrointestinal cancers has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-07-02Clinical Trial Update: Comparison of Secretin-enhanced Magnetic Resonance Cholangiopancreatography (S-MRCP) to Endoscopic Pancreatic Function Test (ePFT) in Diagnosing Pancreatic Exocrine Insufficiency [NA]
This clinical trial comparing Secretin-enhanced MRCP with Endoscopic Pancreatic Function Test for diagnosing pancreatic exocrine insufficien…